ROCHESTER, Minn. — Mayo Clinic says its cardiologists Peter Noseworthy, M.D., and John Giudicessi, M.D., Ph.D., are making strides in detecting a genetic heart condition early, potentially offering prevention before symptoms arise. Their focus is on arrhythmogenic right ventricular cardiomyopathy , a condition that weakens heart cells and can lead to sudden collapse during exercise. "Detecting it earlier could spare patients from heart failure, the need for a transplant or sudden death," said Dr. Noseworthy. Dr. Noseworthy's team uses digital tools and AI to improve early detection. Meanwhile, Dr. Giudicessi connects patient care with laboratory research to explore gene therapy's potential. The researchers utilized Mayo Clinic's Research Data Atlas to identify i

See Full Page